Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Simon Baker is an analyst at Redburn Atlantic. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/26/2025
Buy Now | Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
11/15/2024 | AUTL | Buy Now | Autolus Therapeutics | $1.65 | 687.88% | Simon Baker25% | → $13 | Upgrade | Neutral → Buy | Get Alert |
05/17/2023 | BNTX | Buy Now | BioNTech | $97.22 | 74.86% | Simon Baker25% | $165 → $170 | Upgrade | Neutral → Buy | Get Alert |
02/01/2022 | BNTX | Buy Now | BioNTech | $97.22 | — | Simon Baker25% | — | Upgrade | Sell → Neutral | Get Alert |
10/14/2021 | QGEN | Buy Now | Qiagen | $39.60 | — | Simon Baker25% | — | Initiates | → Buy | Get Alert |
10/14/2021 | ABT | Buy Now | Abbott Laboratories | $125.60 | — | Simon Baker25% | — | Initiates | → Neutral | Get Alert |
10/14/2021 | HOLX | Buy Now | Hologic | $61.23 | — | Simon Baker25% | — | Initiates | → Neutral | Get Alert |
06/16/2021 | BNTX | Buy Now | BioNTech | $97.22 | — | Simon Baker25% | — | Downgrade | Neutral → Sell | Get Alert |
04/08/2020 | FOXA | Buy Now | Fox | $54.81 | -56.21% | Simon Baker25% | $29 → $24 | Upgrade | Sell → Hold | Get Alert |
01/22/2015 | FOXA | Buy Now | Fox | $54.81 | -34.32% | Simon Baker25% | → $36 | Initiates | — | Get Alert |